{
    "organizations": [],
    "uuid": "fccc036e9f30958a537e3824b13934657b38ffd9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-mirati-therapeutics-q4-loss-per-sh/brief-mirati-therapeutics-q4-loss-per-share-0-67-idUSASB0C9LC",
    "ord_in_thread": 0,
    "title": "BRIEF-Mirati Therapeutics Q4 Loss Per Share $0.67",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 8 (Reuters) - Mirati Therapeutics Inc:\n* MIRATI THERAPEUTICS REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS\n* Q4 LOSS PER SHARE $0.67 * Q4 EARNINGS PER SHARE VIEW $-0.61 â€” THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-03-09T05:52:00.000+02:00",
    "crawled": "2018-03-09T14:27:35.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "mirati",
        "therapeutic",
        "inc",
        "mirati",
        "therapeutic",
        "report",
        "fourth",
        "quarter",
        "financial",
        "result",
        "q4",
        "loss",
        "per",
        "share",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}